(Reuters) – The U.S. Food and Drug Administration has approved Medtronic’s deep brain stimulation system for use in patients with Parkinson’s disease, the medical device maker said on Monday.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Leroy Leo)
Comments